# Longevity Stacks 2025 (Live Searches)

## NMN Human Trials
- Renue: 350mg liposomal → NAD+ ↑ (Feb 2025, n=15 men >40).
- WashU VAN: NCT04571008 (complete Sep 2025, organ biology).
- Links: [renuebyscience.com](https://renuebyscience.com/pages/a-current-list-of-completed-nmn-human-trials), [nmn.com](https://www.nmn.com/human-trials).

## Senolytics
- Harvard-Mayo-Cedars: Safe for Alzheimer's risk (2025 pilot: cognition/mobility ↑).
- D+Q weekly: CSF/plasma biomarkers ↓.
- Links: [nmn.com senolytics](https://www.nmn.com/news/new-harvard-study-anti-aging-senolytics-are-safe-for-seniors-with-memory-loss).

## Yamanaka Factors
- YouthBio YB002: FDA greenlight brain reprogramming (Alzheimer's reverse, Sep 2025).
- Partial OSK: Youthful gene expr w/o tumor risk.
- Links: [nmn.com reprogramming](https://www.nmn.com/news/partial-brain-reprogramming-fda-greenlights-first-human-trial).

## Plasma Dilution / Other
- Heterochronic parabiosis: Senescent clear.
- GDF11 MSCs: Angiogenic ↑ (PMC 2025).

DIY: NMN 1g subQ weekly, fasting 72h q3mo. Sats-ledger milestones.
